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ObjectiveaaBenzodiazepines are from the most common drugs which are used for treatment of anxiety disorders. There are other drugs 
with antianxiety properties including antihistamines such as hydroxyzine, too. Body of evidence show that co-administration of two drugs 
which act through different mechanisms, makes the dose of each drug to be reduced, while preserving the desired effect with less adverse 
drug reactions. The aim of this study was to see whether co-administration of subeffective antianxiety doses of diazepam and hydroxyzine 
has any antianxiety effect in elevated zero-maze (EZM) in mice.
MethodsaaTo find the highest subeffective dose of each drug, different doses of hydroxyzine from 1.5 to 24 mg/kg and diazepam in doses 
of 0.25, 0.5 and 1 mg/kg were injected to male mice. Thirty minutes later, the animals were placed on EZM and various parameters of an-
xiety were recorded by a camera to assess later. After determination of subeffective antianxiety dose of the drugs, co-administration of hy-
droxyzine and diazepam was done and the anxiety parameters were measured. 
ResultsaaIn co-administration of 0.25 mg/kg of diazepam and 12 mg/kg hydroxyzine, as subeffective antianxiety doses of either drug, there 
were not any significant differences in main anxiety parameters, i.e., time spent in open areas and open area entries compared to control 
group. Hence, no anxiolytic effect was seen.
ConclusionaaIt seems that subeffective doses of diazepam and hydroxyzine may not have any facilitating or synergistic effect on each 
other in antianxiety responses in mice.  Psychiatry Investig 2011;8:169-173
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INTRODUCTION 
Anxiety is a major symptom of many psychiatric disorders 
and almost always is present in surgical and serious medical 
conditions. In pharmacotherapy of anxiety, benzodiazepines 
and selective serotonin reuptake inhibitors are the mainly used 
drugs. Benzodiazepines are mostly useful in patients who 
have acute anxiety reactions due to their medical or psychiat-
ric disease. Other drugs such as histaminic receptor-1 antag-
onists including hydroxyzine and diphenhydramine also have 
antianxiety properties.
1 
There are concerns about the potential for habituation, tol-
erance and abuse of benzodiazepines. In addition, these drugs 
can impair cognition and motor function, especially in the el-
derly, who may experience confusion, delirium and falls lead-
ing to fractures with lots of morbidity and mortality.
1 Hence, 
reduction of these adverse effects would be of great concern. 
To achieve this goal, one of the strategies could be drug com-
bination therapy, which is used frequently in situations where 
additive or synergistic responses are desired. In some instanc-
es, therapeutic effects are seen with submaximal doses of drugs 
when co-administered, with fewer side effects.
2 In anxiolysis, 
there is also evidence of effective antianxiety activity in animals 
when subeffective doses of antianxiety drugs are co-adminis-
tered.
3-5
In this study, we examined the anxiolytic effect of subeffec-
tive doses of diazepam and hydroxyzine in concert, to achieve 
the desired effective response in mice.170  Psychiatry Investig 2011;8:169-173
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METHODS
Animals
Male NMRI mice from a local breeding centre weighing 25-
30 g were group-housed four per cage with controlled room 
temperature of 22-25 degrees. They were maintained on a 12 : 
12 light-dark cycle and had access to food and water ad libi-
tum. Tests were performed after one day of acclimatization to 
the above environment. All experiments were carried out be-
tween 09 : 00 and 13 : 00 h. Each mouse was tested once on the 
elevated zero-maze (EZM). 
All procedures were conducted in accordance with the in-
ternationally accepted principles for laboratory animal use and 
care. The ethics code designated to this research from the 
ethical committee of Kerman Neuroscience Research Center 
was EC/KNRC/86-21.
Elevated zero-maze
The EZM has been designed in accordance with the origi-
nal description of Shepherd et al.
6 with a little modification. 
Briefly, the apparatus comprised of an annular track (width 5 
cm) with inner diameter of 40 cm, divided into two opposite, 
open quadrants and two opposite, closed quadrants (height of 
the side walls was 15 cm). The open parts have borders (height 
2 mm) for guiding the animal and preventing from falling. To 
measure the distance which animal travel on the apparatus, each 
open and closed area was divided into 10 equal parts by draw-
ing fine lines. 
All parts of the apparatus were made of wood, and the entire 
maze was elevated 40 cm above the floor. Testing was conduct-
ed in a quiet room that was illuminated with four ceiling-mo-
unted, 40-watt, fluorescent light bulbs. 
Experimental design
To begin a test session, mice were placed on the end of the 
open area facing the closed area designated as the starting point 
and were allowed to investigate the zero maze for a period of 
5 min. During this time, several anxiety-related variables were 
recorded by a webcam connected to a computer to analyze later. 
These parameters included the time spent in open area, the num-
ber of entries into open area, the number of head dippings over 
the border of open area, the number of stretch attend postures 
from closed area into the open area and the total distance 
traveled by each mouse on the EZM (by counting the number 
of fine lines on the apparatus crossed by animals, and turning 
the results into centimeter).
Drug administration
First, the anxiolytic dose of each drug was determined. Hy-
droxyzine (Darupakhsh, Iran) at the doses of 1.5, 3, 4.5, 6, 12, 
15, 18 and 24 mg/kg (8 groups) were dissolved in normal sa-
line and administered intraperitoneally. For preparation of 
diazepam solution, one to two drops of Tween 80 (Merck, Ger-
many) were added to normal saline and then diazepam (Che-
midaru, Iran) was added and dissolved. The doses of diaze-
pam used were 0.25, 0.5 and 1 mg/kg (subcutaneously). Thirty 
minutes after injections, the animals were placed on the EZM. 
After determination of the highest sub-anxiolytic dose of ei-
ther drug, both drugs were administered simultaneously by dif-
ferent routes (intraperitoneally and subcutaneously, respective-
ly for hydroxyzine and diazepam), and the relevant solvents 
were injected to another group of animals as the control group 
through the same routes as the main drugs. Thirty minutes lat-
er, the animals were tested as previously described.
In all experiments, at least 6 animals were used in each group.
Statistical analysis
Data were analyzed using one-way analysis of variance, or 
where applicable, Kruskal-Wallis test. If there was a signifi-
cant difference (p<0.05), Holm-Sidak or Dunn’s methods were 
used, respectively. The outliers were excluded by Smirnov-
Gravus’ rejection test. The statistical software used was Sigma-
stat 3.1.
RESULTS
As is seen in Table 1, different doses of hydroxyzine, did not 
make any significant differences in the number of entries into 
open area, the time spent in open area, the number of head dip-
pings and the number of stretch attend postures compared to 
the control group. The total distance traveled in the three high-
er doses (15, 18 and 24 mg/kg) was significantly less than the 
control group (p<0.01, p<0.001 and p<0.001, respectively). In 
addition, animals in these three groups were motionless in a 
crouching position for rather a long period of time.
In animals which received 0.5 mg/kg diazepam (Table 2), th-
ere was a significant difference in the number of entries into 
open area and the time spent in open area compared to the con-
trol group (p<0.01 and p<0.001, respectively). Animals that 
received the highest dose (1 mg/kg) showed a significant incre-
ase in the time spent in open area and the number of stretch at-
tend postures compared to the control animals (p<0.01 and p< 
0.05, respectively).
Animals which received both hydroxyzine (12 mg/kg) and 
diazepam (0.25 mg/kg) did not show any differences in the 
number of entries into open area, the time spent in open area 
and the total distance traveled compared to their controls (Ta-
ble 3). However, the number of head dippings was signifi-
cantly less (p<0.05) and the number of stretch attend postures 
was significantly more than the control group (p<0.05). B Naghibi & F Rayatnia
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DISCUSSION
In this study, the effect of co-administration of subeffective 
doses of two antianxiety agents, hydroxyzine and diazepam, 
that exert their anxiolytic effect through different mechanisms, 
was studied. First, the lowest antianxiety dose of each drug was 
determined. In the case of hydroxyzine, Gladney et al.
7 had in-
vestigated the anxiolytic effect of different doses of hydroxy-
zine (1, 4, 7 and 10 mg/kg) in mice, and only 1 mg/kg of hydro-
xyzine had shown the antianxiety property. Hence, we started 
with the dose of 1.5 mg/kg which seemed to be anxiolytic ac-
cording to that study; however, this dose did not show any an-
tianxiety effect. Then the higher doses (3, 4.5, 6 and 12 mg/kg) 
were studied consecutively, and all of them showed no anxio-
lytic activity. After doubling the last dose, i.e., administration 
of 24 mg/kg, the animals’ locomotor activity, as was evident 
by the total distance traveled, was declined dramatically and 
the mice appeared sleepy. Then the mean dose between 12 and 
24 mg/kg (i.e., 18 mg/kg) was chosen and the experiment re-
peated. A reduction in mice locomotor activity and drowsiness 
was seen again. When the mean dose between 18 and 12 was 
selected, the same results with 24 and 18 mg/kg were observed 
(Table 1), without any significant changes in other anxiety pa-
rameters.
In humans, hydroxyzine exerts its antianxiety effect at doses 
of about 400 mg/day, which lead to marked sedation.
1 It could 
be concluded that the anxiolytic and the hypnotic doses of hy-
droxyzine are very close to each other. Hence, in our study, 
the doses of 15, 18 and 24 mg/kg of hydroxyzine which made 
animals sleepy, were supposed to be anxiolytic, which was op-
posite to what Gladney et al.
7 had reported, but close to the re-
sults of some other studies which indicated that the anxiolyt-
ic dose of hydroxyzine in rats is at least 8 mg/kg,
8,9 and in mice 
should be greater than 4 mg/kg.
10 Consequently, the dose of 12 
mg/kg was determined as the highest dose which did not have 
an antianxiety effect, and was selected as the subeffective dose 
for the rest of the experiment.
For determination of the subeffective dose of diazepam, the 
experiment began with 1 mg/kg diazepam, which was proved 
to be anxiolytic in mice in many studies
11-13 as well as our pre-
vious experiments. This dose was proved to be antianxiety, since 
the time spent in open area was increased and the number of 
stretch attend postures was decreased significantly compared 
to controls (Table 2). Then this dose was halved and the ex-
periment was done by 0.5 mg/kg diazepam. The time spent 
in open area and the number of entries into open area was in-
creased significantly compared to the control group, so this dose 
was also anxiolytic (as in other previous studies
14,15). There were 
no changes in anxiety parameters when diazepam at the dose 
of 0.25 mg/kg was tested. Hence, this dose was selected as the 
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subeffective dose of diazepam. 
The main part of the experiment was done by administra-
tion of 12 mg/kg hydroxyzine and 0.25 mg/kg diazepam simul-
taneously. The two major anxiety parameters, the time spent 
in open area and the number of entries into open area did not 
change when both drugs were co-administered, indicated on 
absence of anxiolysis. Meanwhile, both the number of head 
dippings and the number of stretch attend postures were in-
creased significantly compared to the control group. Although 
an increase in the number of head dippings indicates in anx-
iolysis, the number of stretch attend postures increment shows 
an anxiogenic effect. Hence, it seems a paradoxical result has 
been obtained. However, these are minor anxiety parameters 
and the number of entries into open area and the time spent 
in open area are the most reported and putative anxiety indi-
ces, and overshadow the results of the number of head dip-
pings and the number of stretch attend postures. Co-admin-
istration of hydroxyzine and diazepam had no effect on lo-
comotor activity of mice as was evident by the lack of signi-
ficant changes in the total distance traveled (Table 3). From all 
above, it seems that at subeffective doses, co-administration 
of these two agents did not have an antianxiety property in 
mice. In the work of Gladney et al.,
7 concurrent administra-
tion of hydroxyzine and chloral hydrate did not result in addi-
tive or synergistic anxiolytic effect, either. However, there are 
reports that the co-administration of subeffective doses of some 
drugs does have anxiolytic properties. Xu et al.
3 have reported 
that the subeffective dose of baicalin, a naturally occurring fla-
vonoid with anxiolytic-like effect, has additive response with the 
subeffective dose of diazepam. Similarly, concurrent admin-
istration of subeffective doses of Withania somnifera with an-
tianxiety activity and ethanol,
16 subeffective doses of magne-
sium and diazepam or chlordiazepoxide,
5 Naloxone, which does 
not have the antianxiety property by itself, used with subeffec-
tive doses of diazepam, chlordiazepoxide and buspirone,
17 re-
sulted in additive or synergistic effects. 
There are also some reports that in anxiolysis, different sys-
tems can have facilitating effects on each other. Serotonergic 
system, through serotonin 5-HT2A receptors, has shown to 
facilitate the action of γ-aminobutyric acid (GABA) in allevi-
ating anxiety.
4 Hydroxyzine, in addition to its antihistaminic 
properties, has antimuscarinic effects,
18,19 which may be re-
sponsible for its sedative effects,
20 although its antianxiety ef-
fect is also attributed to histamine-1 receptor blockage.
19 Hence 
both antihistaminic and anticholinergic properties of hydroxy-
zine, alone or in combination, may be involved in its sedative 
effect. Although it is clear that the concurrent use of therapeu-
tic doses of hydroxyzine and other central nervous system de-
pressants produces an additive effect in sedation, which can 
even lead to the impairment of motor function;
20 however, us-
ing subeffective doses of diazepam and hydroxyzine together 
may not have the facilitating effect on each other. According to 
our results, it seems that neither antihistaminic, nor antimus-
carinic properties of hydroxyzine have facilitatory effect on GA-
BAergic system in anxiolysis in mice.
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